Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 4, 2000, Pages 947-958

  Akabani, Gamal ^a   Cokgor, Ilkcan ^a   Coleman, R Edward ^a   González Trotter, Dinko ^a   Wong, Terence Z ^a   Friedman, Henry S ^a   Friedman, Allan H ^a   Garcia Turner, Ana ^a   Herndon II, James E ^a   Delong, David ^a   McLendon, Roger E ^a   Zhao, Xiao Guang ^a   Pegram, Charles N ^a   Provenzale, James M ^a   Bigner, Darell D ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain tumors; Dosimetry; Radioimmunotherapy

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY; TENASCIN MONOCLONAL ANTIBODY 81C6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN TISSUE; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DOSIMETRY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOISOTOPE THERAPY;

ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOIMMUNOTHERAPY; TENASCIN;

EID: 0034002829     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00500-3     Document Type: Article

References (34)

1. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose-response relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 5:1979;1725-1731.
2. Walker M.D., Alexander E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas; a co-operative clinical trial. J Neurosurg. 49:1978;333-343.
3. Sheline G.E. Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys. 18:1990;793-803.
4. Davies E., Clarke C., Hopkins A. Malignant cerebral glioma - I Survival, disability, and morbidity after radiotherapy . Br Med J. 313:1996;1507-1512.
5. Chang C.H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J.S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study . Cancer. 52:1983;997-1007.
6. Miller P.J., Hassanein R.S., Giri P.G., Kimler B.F., O'Boynick P., Evans R.G. Univariate and multivariate statistical analysis of high-grade gliomas The relationship of radiation dose and other prognostic factors . Int J Radiat Oncol Biol Phys. 19:1990;275-280.
7. Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 6:1980;1215-1228.
8. Marks J.E., Baglan R.J., Prassad S.C., Blank W.F. Cerebral radionecrosis Incidence and risk in relation to dose, time, fractionation and volume . Int J Radiat Oncol Biol Phys. 7:1981;243-252.
9. Burger P.C., Heinz E.R., Shibata T., Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg. 68:1988;698-704.
10. Leibel S.A., Gutin P.H., Wara W.M., et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 17:1989;1129-1139.
11. Leibel S.A., Scott C.B., Loeffler J.S. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol. 21:1994;198-219.
12. Green SB, Shapiro WR, Burger PC, Selker RG, VanGilder JC, Saris S, Malkin MG, Mealy J, Neal J, Robertson JT, Olson J. A randomized trial of interstitial radiotherapy (RT) boost for newly diagnosed malignant glioma: Brain Tumor Cooperative Group (BTCG) Trial 8701. Proceedings of the American Society of Clinical Oncology, Dallas, TX; 1994. p. 174.
13. Shrieve D.C., Alexander E. III, Wen P.Y., et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 36:1995;275-284.
14. Wen P.Y., Alexander E. III, Black P.M., et al. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer. 73:1994;3029-3036.
15. Addesa AE, Shrieve DC, Alexander A III; et al. Stereotactic radiosurgery as primary adjuvant treatment for glioblastoma: The JCRT update. Proceedings Am Society Clin Oncol 31st Annual Meeting. Los Angeles, 144, 1995.
16. Wood J.R., Green S.B., Shapiro W.R. The prognostic importance of tumor size in malignant gliomas A computed topographic scan study by the Brain Tumor Cooperative Group . J Clin Oncol. 6:1988;338-343.
17. Marks L.B., Specnce D.P. The influence of volume on the tolerance of the brain to radiosurgery. J Neurosurg. 75:1991;177-180.
18. Larson D.A., Wara W.M. Radiotherapy of primary malignant brain tumors. Semin Surg Oncol. 14:1998;34-42.
19. 131I monoclonal antibody Feasibility, pharmacokinetics and dosimetry . Br J Cancer. 67:1993;144-151.
20. Riva P., Arista A., Tison V., et al. Intralesional radioimmunotherapy of malignant gliomas An effective treatment in recurrent tumors . Cancer. 73:1994;1076-1082.
21. Hopkins K., Chandler C., Bullimore J., et al. A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates. Radiother Oncol. 34:1995;121-131.
22. Bigner D.D., Brown M.T., Friedman A.H., et al. Iodine-131-labeled anti-tenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas Phase I trial results . J Clin Oncol. 16:1998;2202-2212.
23. Akabani G., Reist C.J., Cokgor I., Friedman A.H., Friedman H.S., Coleman R.E., Zhao X.G., Bigner D.D., Zalutsky M.R. Dosimetry of I-131 labeled 81C6 monoclonal antibody administered into surgically created resection cavities in malignant brain tumor patients. J Nucl Med. 40:1999;631-638.
24. Zalutsky M.R., Moseley R.P., Coakham H.B., Coleman R.E., Bigner D.D. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res. 49:1989;2807-2813.
25. Lindmo T., Boven E., Cuttitta F., Fedorko J., Bunn P.A. Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 72:1984;77-89.
26. Rubin P., Casarett G.W. Central nervous system. Rubin P., Casarett G.W. Clinical radiation pathology. Vol. II:1968;609-661 W. B. Saunders, Philadelphia, London, Toronto.
27. 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma A model to estimate absorbed radiation dose . Int J Radiat Oncol Biol Phys. 40:1998;835-844.
28. Sgouros G. Bone marrow dosimetry for radioimmunotherapy Theoretical considerations . J Nucl Med. 34:1993;689-694.
29. Akabani G., Poston J.W. Sr, Bolch W.E. Estimates of absorbed fractions in small volumes for selected radionuclides. J Nucl Med. 32:1991;835-839.
30. Leibel S.A., Gutin P.H., Davis R.L. Factors affecting radiation injury after interstitial brachytherapy for brain tumors. Gutin P.H., Leibel S.A., Sheline G.E. Radiation injury to the nervous system. 1991;Raven Press, New York.
31. Hoshino T. A commentary on the biology and growth kinetics of low grade and high grade gliomas. J Neurosurg. 61:1984;895-900.
32. Sneed P.K., Lamborn K.R., Larson D.A., Prados M.D., Malec M.K., McDermott M.W., Weaver K.A., Phillips T.L., Wara W.M., Gutin P.H. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 35:1996;37-44.
33. Mehta M.P., Masciopinto J., Rozental J., Levin A., Chappell R., Bastin K., Miles J., Turski P., Kubsad S., Mackie T., et al. Stereotactic radiosurgery for glioblastoma multiforme Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage . Int J Radiat Oncol Biol Phys. 30:1994;541-549.
34. Barker F.G. 2nd, Prados M.D., Chang S.M., Gutin P.H., Lamborn K.R., Larson D.A., Malec M.K., McDermott M., Sneed P.K., Wara W.M., Wilson C.B. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg. 84:1996;442-448.